gray market peptides retatrutide Since January 2026, there have been six cases of acute liver toxicity associated with unapproved peptide products labelled in Australia. These toxic effects may be linked to a contaminant in the InSight+ | Grey-market peptides: an

Blood pressure reductions observed in clinical trials, averaging nearly 10 mm Hg systolic and 4 mm Hg diastolic, translate to meaningful cardiovascular risk reduction

Letters in Drug Design & Discovery

Yes, many patients take both medications safely under medical supervision

In the same 2025 study by Qeadan and colleagues, individuals with a history of opioid use disorder (n=503,747) prescribed GLP-1 medications had about a 40% lower rate of opioid overdose events during the 2-year follow-up period (Qeadan et al., 2025)

Xun Sun (Indiana University School of Medicine) for helpful discussion

B.JanmohamedS.D'agostinoR